Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/1999
05/14/1999WO1999022731A1 Method and composition for treatment of sexual dysfunction
05/14/1999WO1999022730A1 Use of (+)-6-carboxamido-3-methylamino-1,2,3,4-tetrahydrocarbazole for treating hyperalgesia
05/14/1999WO1999022729A1 The use of proteasome inhibitors for treating cancer, inflammation, autoimmune disease, graft rejection and septic shock
05/14/1999WO1999022728A1 Methods and compositions for regulation of 5-alpha reductase activity
05/14/1999WO1999022727A1 Pharmaceutically active composition containing artemisinine and/or a derivative of artemisinine
05/14/1999WO1999022726A1 N,n'-bis(sulfonyl)hydrazines useful as antineoplastic agents
05/14/1999WO1999022725A1 Method for modifying the growth rate, feed efficiency and body composition of domestic animals
05/14/1999WO1999022724A2 Extended release formulation containing venlafaxin
05/14/1999WO1999022723A1 Epi-inositol compositions for the treatment of cns disorders
05/14/1999WO1999022722A2 Use of macrolides for the treatment of cancer and macular degeneration
05/14/1999WO1999022721A2 Unsubstituted polydiallylamine for treating hypercholesterolemia
05/14/1999WO1999022720A2 Selective cyclooxygenase-2 inhibitors against premature labor
05/14/1999WO1999022717A1 Novel formulation for use in pain management
05/14/1999WO1999022716A1 Topical compositions for nsai drug delivery
05/14/1999WO1999022714A1 Topical compositions for prostaglandin e1 delivery
05/14/1999WO1999022713A1 Sustained release ophthalmic compositions containing water soluble medicaments
05/14/1999WO1999022707A1 Composition for topical application on the skin and/or its appendages comprising at least a compound containing an iminophenol fragment
05/14/1999WO1999022703A1 Improved personal care formulations
05/14/1999WO1999022700A1 Personal care compositions suitable for styling hair
05/14/1999WO1999022609A1 System, method and composition for dialysis and shock treatment
05/14/1999WO1999022593A1 Use of exochelins in the preservation of organs for transplant
05/14/1999WO1999013862A3 A pharmaceutical composition for treating dysmenorrhea and premature labor
05/14/1999WO1999010338A3 Benzylidene- and cinnamylidene-anabaseines as neuronal nicotinic alpha-7 receptor agonists
05/14/1999WO1999007692A3 New epothilone derivatives, method for producing same and their pharmaceutical use
05/14/1999WO1999007368A9 Antimutagenic agents
05/14/1999WO1999007352A3 Method for promoting expression of ldl receptor gene
05/14/1999WO1999007351A3 Indole derivatives and their use as mcp-1 antagonists
05/14/1999WO1999005269A8 Transcriptional silencer protein nrf
05/14/1999WO1999004769A3 Use of aminoacridines for the treatment of solid tumours, metastases and lymphomas
05/14/1999WO1999003509A3 Pharmaceutical products containing triiodoaromats containing perfluoroalkyl groups, and the use thereof in the treatment of tumours and interventional radiology
05/14/1999WO1999002134A3 Method for producing active agent preparations with controlled release from a matrix
05/14/1999WO1999001467A3 Therapeutically active compounds with low systemic activity due to reduce half life
05/14/1999WO1999001124A9 Synthesis of epothilones, intermediates thereto, analogues and uses thereof
05/14/1999WO1998058965A3 B7-binding molecules for treating immune diseases
05/14/1999WO1998058915A3 Pyrimidin-2,4,6-trion derivatives and their use as metalloprotease-inhibitors
05/14/1999WO1998052549B1 Use of fumaric acid derivatives
05/14/1999WO1998051289A3 Monoesters of probucol for the treatment of cardiovascular and inflammatory disease
05/14/1999WO1998033904A3 An antisense oligonucleotide preparation method
05/14/1999WO1998014593A9 Human telomerase catalytic subunit
05/14/1999WO1997035539A3 Arylamino fused pyridines and pyrimidines
05/14/1999CA2681877A1 Arylpiperidinopropanol and arylpiperazinopropanol derivatives and pharmaceuticals containing the same
05/14/1999CA2315221A1 Method and composition for treatment of sexual dysfunction
05/14/1999CA2309175A1 Therapeutically active compounds based on indazole bioisostere replacement of catechol in pde4 inhibitors
05/14/1999CA2309165A1 Topical compositions for prostaglandin e1 delivery
05/14/1999CA2309150A1 Indazole bioisostere replacement of catechol in therapeutically active compounds
05/14/1999CA2309122A1 Novel formulation for use in pain management
05/14/1999CA2308852A1 Rnase l activators and antisense oligonucleotides effective to treat rsv infections
05/14/1999CA2308639A1 Method of using cyclooxygenase-2 inhibitors in maintaining the fetal ductus ateriosus during treatment and prevention of preterm labor
05/14/1999CA2308512A1 Use of exochelins in the preservation of organs for transplant
05/14/1999CA2308428A1 Aromatic heterocyclic compounds as anti-inflammatory agents
05/14/1999CA2308385A1 Antimutagenic compositions for treatment and prevention of photodamage to skin
05/14/1999CA2308317A1 Novel metal complexes
05/14/1999CA2308316A1 Novel metal complexes
05/14/1999CA2308151A1 Biphenyl derivatives as pharmaceuticals
05/14/1999CA2308135A1 Novel metal complexes
05/14/1999CA2308091A1 Inducible phosphofructokinase and the warburg effect
05/14/1999CA2308018A1 Ribozymes targeted to il-15 mrna
05/14/1999CA2307905A1 3-aminoalkylamino-2h-1,4-benzoxazines and 3-aminoalkylamino- 2h-1,4-benzothiazines: dopamine receptor subtype specific ligands
05/14/1999CA2307886A1 Improved personal care formulations
05/14/1999CA2307853A1 Diaryl-5-alkyl-5-methyl-2(5h)-furanones as selective cyclooxygenase-2 inhibitors
05/14/1999CA2307850A1 Use of macrolides for the treatment of cancer and macular degeneration
05/14/1999CA2307839A1 Gene involved in metabolic energy and obesity
05/14/1999CA2307770A1 Novel carboxylic acid derivatives which carry amide side chains, production of said carboxylic acid derivatives and their use as endothelin receptor antagonists
05/14/1999CA2307560A1 System, method and composition for dialysis and shock treatment
05/14/1999CA2307097A1 Compositions of lipid lowering agents
05/14/1999CA2306866A1 Methods and compositions for treating dermatoses
05/14/1999CA2305242A1 Extended release formulation
05/14/1999CA2302379A1 Sustained release ophthalmic compositions containing water soluble medicaments
05/14/1999CA2300198A1 Use of quinapril for treating myocardial ischemia and angina
05/14/1999CA2276013A1 The use of proteasome inhibitors for treating cancer, inflammation, autoimmune disease, graft rejection and septic shock
05/14/1999CA2249952A1 Rapidly soluble solid in the oral cavity and process for producing the same
05/13/1999CA2253119A1 Hydrophilizing agent precursor, a process for its preparation and its use as a dispersing agent for aqueous polyurethane dispersion
05/12/1999EP0915162A2 Adenine phosphoribosyltransferase
05/12/1999EP0915161A2 DnaG DNA primase of Streptococcus pneumoniae
05/12/1999EP0915157A2 Method for the preparation of functional recombinant tissue factor
05/12/1999EP0915094A1 Morphinane derivatives and medicinal use thereof
05/12/1999EP0915093A1 Amide derivatives
05/12/1999EP0915090A1 Compounds useful as hypoglycemic agents and for treating Alzheimer's disease
05/12/1999EP0915088A1 D-Proline derivatives
05/12/1999EP0915087A2 Sulfonamide substituted fused five-membered ring compounds, their use as medicaments as well as pharmaceutical compositions containing them
05/12/1999EP0915086A1 Phenylsulfonamide derivatives
05/12/1999EP0914862A1 Novel adsorbent
05/12/1999EP0914828A2 Use of des-aspartate-angiotensin I
05/12/1999EP0914826A1 Wound healing accelerators
05/12/1999EP0914825A2 Methods for preparation of 1 alpha, 24-dihydroxy vitamin D2
05/12/1999EP0914824A1 Preventive and remedy for viral infections
05/12/1999EP0914823A1 Sustained release preparation comprising tramadol and a preparation for its production
05/12/1999EP0914822A1 Rapid-release microdispersible ecadotril preparation
05/12/1999EP0914821A2 Method for diagnosis of atherosclerosis involving measurement of NADPH oxidase activity
05/12/1999EP0914605A1 Molecular model for vla-4 inhibitors
05/12/1999EP0914460A1 Vehicle for the transport of molecular substances
05/12/1999EP0914459A2 Adenoviral mediated gene transfer in adipocytes and related implants
05/12/1999EP0914453A1 HUMAN INTERLEUKIN-1j AND ANTAGONISTS THEREOF
05/12/1999EP0914448A1 Lipid kinase
05/12/1999EP0914443A2 Use of a modified rev-responsive element (rre) in methods and compositions for combatting hiv infection
05/12/1999EP0914440A1 Nucleic acid vaccination for parvoviral infections
05/12/1999EP0914435A1 Hybrid interferon compositions and methods of use
05/12/1999EP0914432A2 Secreted proteins and polynucleotides encoding them
05/12/1999EP0914428A2 Genetic sequences and proteins related to alzheimer's disease, and uses therefor
05/12/1999EP0914426A1 Sequences ahead of gene sm22, vectors containing same, and therapeutical uses thereof, particularly for treating vascular diseases
1 ... 6500 6501 6502 6503 6504 6505 6506 6507 6508 6509 6510 6511 6512 6513 6514 6515 6516 6517 6518 6519 6520 ... 7860